Is GBIO or STAG a better dividend investment in 2026?

GBIO currently yields 37.45% with a 5% 5-year dividend growth rate. STAG yields 3.44% with 1% growth. The better choice depends on your goal: GBIO offers higher current income.

What is the dividend yield difference between GBIO and STAG?

GBIO has a forward dividend yield of 37.45% ($2.00/share annually). STAG yields 3.44% ($1.24/share annually). The yield gap is 34.01 percentage points.

Home › Compare › GBIO vs STAG

GBIO vs STAG: Dividend Comparison 2026

GBIO yields 37.45% · STAG yields 3.44%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GBIO wins by $183.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

GBIO

● Live price

37.45%

Share price

$5.34

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$201.6K

Annual income

$32,248.55

Full GBIO calculator →

STAG

STAG Industrial Inc.

● Live price

3.44%

Share price

$36.09

Annual div

$1.24

5Y div CAGR

0.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$18.3K

Annual income

$462.22

Full STAG calculator →

Portfolio growth — GBIO vs STAG

📍 GBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GBIO	STAG
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GBIO + STAG cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GBIO pays

STAG pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBIO

Annual income on $10K today (after 15% tax)

$3,183.52/yr

After 10yr DRIP, annual income (after tax)

$27,411.27/yr

STAG

Annual income on $10K today (after 15% tax)

$292.45/yr

After 10yr DRIP, annual income (after tax)

$392.89/yr

At 15% tax rate, GBIO beats the other by $27,018.38/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBIO + STAG for your $10,000?

GBIO: 50%STAG: 50%

100% STAG50/50100% GBIO

Portfolio after 10yr

$110.0K

Annual income

$16,355.38/yr

Blended yield

14.87%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

GBIO

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$5.25

-1.7% upside vs current

Range: $5.00 — $5.50

Altman Z

-9.1

Piotroski

1/9

STAG

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$45.00

+24.7% upside vs current

Range: $39.00 — $59.00

Altman Z

1.2

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBIO buys

STAG buys

No recent congressional trades found for GBIO or STAG in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGBIOSTAG

Forward yield	37.45% ✓	3.44%
Annual dividend / share	$2.00 ✓	$1.24
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0.3% ✓
Portfolio after 10y	$201.6K ✓	$18.3K
Annual income after 10y	$32,248.55 ✓	$462.22
Total dividends collected	$148.7K ✓	$4.0K
Payment frequency	quarterly	monthly
Sector	Stock	REIT
Analyst consensus	Buy	Buy
Analyst price target	$5.25	$45.00 ✓

Year-by-year: GBIO vs STAG ($10,000, DRIP)

Year	GBIO Portfolio	GBIO Income/yr	STAG Portfolio	STAG Income/yr	Gap
1← crossover	$14,445	$3,745.32	$10,665	$345.09	+$3.8K → GBIO
2	$20,513	$5,056.29	$11,364	$357.70	+$9.1K → GBIO
3	$28,659	$6,710.36	$12,098	$370.43	+$16.6K → GBIO
4	$39,427	$8,761.91	$12,869	$383.28	+$26.6K → GBIO
5	$53,452	$11,265.44	$13,677	$396.23	+$39.8K → GBIO
6	$71,468	$14,273.72	$14,524	$409.27	+$56.9K → GBIO
7	$94,307	$17,835.96	$15,411	$422.41	+$78.9K → GBIO
8	$122,904	$21,996.02	$16,339	$435.61	+$106.6K → GBIO
9	$158,298	$26,790.73	$17,311	$448.89	+$141.0K → GBIO
10	$201,627	$32,248.55	$18,327	$462.22	+$183.3K → GBIO

GBIO vs STAG: Complete Analysis 2026

GBIO — Stock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Full GBIO Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →

📬

Get this GBIO vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBIO vs SCHD GBIO vs JEPI GBIO vs O GBIO vs KO GBIO vs MAIN GBIO vs PLD GBIO vs EQR GBIO vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.